ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,012Medicare Part D Prescriptions Filled, Including Refills

Rank: 255 out of 939

$1.05M Total Retail Price of All Prescriptions

Rank: 39 out of 939

616 Patients Receiving at Least One Drug in Part D
60%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 616 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

29% of this provider’s 616 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 4,598 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$105 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
HYDROCODONE-ACETAMINOPHEN 918 304 S3 1 1
CARISOPRODOL 216 11 R 2 51
AMLODIPINE BESYLATE 204 156 3 6
LEVOTHYROXINE SODIUM 203 123 4 4
ZOLPIDEM TARTRATE 193 107 5 20
OMEPRAZOLE 182 84 6 5
LISINOPRIL 173 127 7 3
METFORMIN HCL 153 77 8 8
OXYCODONE HCL-ACETAMINOPHEN 149 20 S2 9 107
FUROSEMIDE 142 64 10 7
OXYCODONE HCL 136 0 S2 11 67
NEXIUM 135 46 12 18
POTASSIUM CHLORIDE 130 75 13 9
SIMVASTATIN 130 55 13 2
GABAPENTIN 127 34 15 11
FENTANYL 124 30 S2 16 104
CITALOPRAM HBR 123 40 17 15
CYCLOBENZAPRINE HCL 116 14 R 18 36
CYMBALTA 107 32 19 44
PRAVASTATIN SODIUM 103 74 20 13
TRAMADOL HCL 94 57 21 16
LYRICA 90 14 22 63
TAMSULOSIN HCL 89 76 23 27
PROMETHAZINE HCL 85 15 R 24 68
CLOPIDOGREL 83 57 25 28
DIOVAN 80 43 26 50
METOPROLOL TARTRATE 79 53 27 10
CARVEDILOL 77 46 28 25
HYDROCHLOROTHIAZIDE 77 56 28 12
MELOXICAM 73 49 30 14
DEXILANT 71 0 31 212
BUMETANIDE 71 48 31 124
LISINOPRIL-HYDROCHLOROTHIAZIDE 70 48 33 23
ADVAIR DISKUS 69 45 34 60
PLAVIX 69 53 34 48
ATORVASTATIN CALCIUM 69 32 34 22
SYNTHROID 65 51 37 75
TIZANIDINE HCL 64 17 38 81
ESCITALOPRAM OXALATE 64 37 38 61
SPIRIVA 64 42 38 73
LOSARTAN POTASSIUM 62 34 41 29
RAMIPRIL 61 24 42 91
WARFARIN SODIUM 60 49 43 17
AZITHROMYCIN 59 31 44 32
LUNESTA 58 48 45 265
PREDNISONE 58 27 45 42
VENTOLIN HFA 57 19 47 80
TRIAMTERENE-HCTZ 56 41 48 33
PANTOPRAZOLE SODIUM 54 38 49 66
DONEPEZIL HCL 51 51 50 30
POLYETHYLENE GLYCOL 3350 50 21 51 57
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 25, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.